The widespread practice of payments for prescriptions, where pharmaceutical companies pay doctors in cash or kind, to generate prescriptions and increase sales, continues unabated, as the government drags its feet to bring in a stringent regulation.A study co-authored by Dr Arun Gadra and Dr Archana Diwate, titled ‘Promotional Practices of the Pharmaceutical Industry and Implementation Status of Related Regulatory Codes in India’, documents unethical practices and failure of regulations while also offering suggestions to improve the exiting regulatory framework.The study is based on 50 in-depth interviews conducted across six cities, primarily involving medical representatives who are the front-line key persons on the field promoting drugs to doctors.Close It highlights direct deals between pharma companies and doctors, citing some cases, for instance, where pharma companies pay installments on a doctor’s car purchase. There were extreme cases, where a few doctors even ‘demand women for entertainment’. related news Sonia Gandhi condoles loss of lives in Delhi fire incident, urges authorities to provide all assistance 373 infra projects show cost overruns of Rs 3.89 lakh cr Unnao rape victim’s sister says family won’t perform last rites unless CM Yogi reaches village The study’s key findings point towards the trends in promotional strategies which have… Read full this story
- How to avoid weight gain in lockdown: Personal trainer shares simple tricks to help you stay in shape at home - and reveals why brushing your teeth after every meal is a must
- Pharma, FMCG, auto stocks top bets in this market: V Srivatsa of UTI MF
- Mike Pompeo tells China to mark Earth Day by BANNING wet markets selling wildlife - like the Wuhan one blamed for the spread of coronavirus
- Why Hasn’t the Stock Market Crashed Even More?
- IMF's Georgieva underscores need to help Africa, other emerging markets
- Changes needed so farmers markets can operate safely
- Strategy in a market like this should be to buy quality largecaps: Kunj Bansal
- Domestic pharma getting multiples closer to FMCG than US generic pharma: Ravi Dharamshi
- Sebi extends derivative curbs up to May 28 as market remains choppy
- Financials best beta shot whenever the market goes down: Susmit Patodia
Pharma wrap: Why we need to give teeth to regulation to curb unethical pharma marketing practices have 361 words, post on www.moneycontrol.com at December 8, 2019. This is cached page on Business Breaking News. If you want remove this page, please contact us.